文献速递肿瘤 PET/CT

18F-FDG PET与MRI影像组学预测局部进展期直肠癌新辅助治疗反应

Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-01-13

单参数分析中PET均匀性AUC最高(0.77),多参数逻辑回归模型含6个二阶纹理特征时AUC达0.86。作者认为若初步结果获证实,治疗前PET与MRI有望用于个体化治疗。

要点

  • 治疗前PET均匀性单参数预测病理应答AUC为0.77,敏感度72.7%、特异度76.7%。
  • 含5个PET与1个T2w MRI二阶纹理特征的逻辑回归模型AUC为0.86。
  • 多参数模型在Youden指数下敏感度86%、特异度83%。

核心结论

  • 治疗前18F-FDG PET与MRI纹理特征有望预测局部进展期直肠癌新辅助治疗后的病理应答,多参数模型预测能力优于单参数特征。

研究设计与样本

  • 从T2w MRI、ADC图及PET/CT半自动分割肿瘤中提取一阶参数与21个基于灰度共生矩阵的二阶纹理参数,采用单参数与多参数模型评估预测价值。

主要发现

  • 单参数分析中PET均匀性AUC最高(0.77;敏感度72.7%、特异度76.7%)。
  • PET糖酵解体积与ADC不相似度敏感度最高(均为90.9%)。
  • 多参数逻辑回归模型含6个二阶纹理特征(5个来自PET、1个来自T2w MRI),区分应答者与无应答者的AUC为0.86,Youden指数下敏感度86%、特异度83%。

关键数值与推荐

  • 病理应答按肿瘤退缩分级定义:应答者为TRG=1或2,无应答者为TRG=3至5。
  • 多参数模型预测病理应答的AUC=0.86,敏感度86%、特异度83%(Youden指数)。
  • 单参数PET均匀性预测病理应答的AUC=0.77,敏感度72.7%、特异度76.7%。

临床怎么用

  • 治疗前可考虑联合PET与MRI纹理特征评估局部进展期直肠癌新辅助治疗应答可能性,辅助个体化治疗决策。
  • 对预测为无应答的患者,或可避免新辅助治疗的毒性,但需待结果进一步验证。

局限性

  • 作者称结果为初步结果,需进一步研究证实。
  • 为单中心研究,纹理特征提取与模型的外部可推广性尚未验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Pathological complete response (pCR) following neoadjuvant chemoradiotherapy or radiotherapy in locally advanced rectal cancer (LARC) is reached in approximately 15-30% of cases, therefore it would be useful to assess if pretreatment of 18F-FDG PET/CT and/or MRI texture features can reliably predict response to neoadjuvant therapy in LARC. METHODS: Fifty-two patients were dichotomized as responder (pR+) or non-responder (pR-) according to their pathological tumor regression grade (TRG) as follows: 22 as pR+ (nine with TRG = 1, 13 with TRG = 2) and 30 as pR- (16 with TRG = 3, 13 with TRG = 4 and 1 with TRG = 5). First-order parameters and 21 second-order texture parameters derived from the Gray-Level Co-Occurrence matrix were extracted from semi-automatically segmented tumors on T2w MRI, ADC maps, and PET/CT acquisitions. The role of each texture feature in predicting pR+ was assessed with monoparametric and multiparametric models. RESULTS: In the mono-parametric approach, PET homogeneity reached the maximum AUC (0.77; sensitivity = 72.7% and specificity = 76.7%), while PET glycolytic volume and ADC dissimilarity reached the highest sensitivity (both 90.9%). In the multiparametric analysis, a logistic regression model containing six second-order texture features (five from PET and one from T2w MRI) yields the highest predictivity in distinguish between pR+ and pR- patients (AUC = 0.86; sensitivity = 86%, and specificity = 83% at the Youden index). CONCLUSIONS: If preliminary results of this study are confirmed, pretreatment PET and MRI could be useful to personalize patient treatment, e.g., avoiding toxicity of neoadjuvant therapy in patients predicted pR-.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Giannini V, Mazzetti S, Bertotto I, et al. Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features. Eur J Nucl Med Mol Imaging. 2019. PMID: 30637502. doi:10.1007/s00259-018-4250-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。